3 May 2024
Latham & Watkins Advises Alkermes on Sale of Athlone, Ireland Facility to Novo Nordisk
Advising firms
Deal team
8 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Aaron Gardner Lead | Latham & Watkins LLP | Partner | Not stated | New York |
| Julie Scallen Lead | Latham & Watkins LLP | Partner | Not stated | Boston |
| Eliot Choy | Latham & Watkins LLP | Counsel | Not stated | New York |
| Oliver Mobasser | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Zhao Wang | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Austin Wruble | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Jake Hummer | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Jihoo Kim | Latham & Watkins LLP | Associate | Not stated | Not stated |
5 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 91m (US$91 million)
- What the figure measures
- Total transaction value
- Client
- Alkermes plcSell-side
- Counterparties
- Novo Nordisk (Buy-side)